PRESS-RELEASE ·Filed Apr 27, 2026
Press release: fda
Actionable Insight • Neutral
No immediate trading catalyst. Monitor actual data presentations at ADA in June 2026 for potential stock-moving results.
Final — all horizons settled through T+60d
GPCR ▲ +16.62% at T+60d
NEUTRAL call ✓ call won +16.62% · α vs SPY +12.63% · entry $43.56 → $50.80
T+1d
-4.26%
call -4.26% · α -4.25%
$41.71
settled 5mo ago
T+5d
-1.19%
call -1.19% · α -2.89%
$43.04
settled 5mo ago
T+20d
-9.14%
call -9.14% · α -14.60%
$39.58
settled 4mo ago
T+60d
+16.62%
call +16.62% · α +12.63%
$50.80
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Structure Therapeutics announced multiple presentations at the ADA 86th Scientific Sessions, including an oral presentation of Phase 2b ACCESS trial data for aleniglipron. No clinical results were disclosed in this press release.
Key Facts
- Five presentations at ADA 2026 including oral on ACCESS Phase 2b trial of aleniglipron
- Combination therapy data with oral GLP-1 and amylin receptor agonists in NHPs
- Lower starting dose data to improve GI tolerability
- No clinical efficacy or safety data released in this announcement
Financial Impact
No financial impact from this press release alone.
Risk Factors
- Clinical trial failure risk for aleniglipron
- Intense competition from injectable GLP-1 drugs (semaglutide, tirzepatide)
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (23 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3282005 |
6 reports for GPCR
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 11, 2026 16w ago | Institutional Cluster | $43.30 $47.34 | ▼ −9.33% | ▼ −4.93% | $27.67 (+36.10%) |
May 7, 2026 21w ago | 8-K | $39.10 $49.64 | ▲ +26.96% | ▲ +22.12% | $27.67 (−29.23%) |
Apr 27, 2026 22w ago | Press Release | $43.56 $50.80 | ▲ +16.62% | ▲ +12.63% | $27.67 (−36.48%) |
Apr 15, 2026 24w ago | 8-K | $54.25 $53.36 | ▼ −1.64% | ▼ −9.78% | $27.67 (−49.00%) |
Mar 16, 2026 28w ago | Press Release | $56.65 $37.77 | ▼ −33.33% | ▼ −43.81% | $27.67 (−51.16%) |
Feb 28, 2026 30w ago | Institutional Cluster | $62.90 $39.58 | ▼ −37.07% | ▼ −46.40% | $27.67 (−56.01%) |
Showing 6 of 6
US Market Status
Market Closed — Opens Mon (65h)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access